COVID isolation cuts priotizes business over health, say scientists

The US national health agency’s decision to slash the isolation time for people with asymptomatic COVID-19 has raised concern among scientists who say the decision will increase the spread of the coronavirus and overburden hospitals.

On Monday, the Centers for Disease Control and Prevention said people with asymptomatic COVID-19 only need to be in isolation for five days and don’t need a negative PCR or rapid antigen test. The five days of isolation must be followed by five days of wearing a mask around others.

The same rule would apply to people whose symptoms were resolving after five days in isolation.

The decision comes amid fears of staff shortages in industries such as health care and tourism. The US has also faced a shortage of rapid-antigen tests in recent weeks.

The CDC says the recommendation is motivated by scientific data that show that the majority of SARS-COV-2 transmission usually occurs one to two days prior to the onset of symptoms and two to three days after.

Scientists want to see data

The data that the CDC used to make its recommendations have not been made publicly available.

A study published in the JAMA Internal Medicine journal in August  found that the transmission potential was highest two days before and three days after the onset of symptoms. But it is still possible to transmit the virus after three days.

“The original quarantine periods are set based on what we’ve found scientifically about how long we detect live virus — in other words, that the person could possibly infect others,” Emma Hodcroft, a molecular epidemiologist at the University of Bern in Switzerland, told DW.

Zoe Hyde, an epidemiologist at the University of Western Australia, told DW that, because people are most infectious in the first few days, shortening the isolation period makes some sense, but only if there is a negative test.

“I think it’s a very bad idea to do away with the need to test negative, because it’s going to lead to a lot of people spreading the virus in the community,” Hyde said.

“It also sends the wrong message about how serious the virus is. It might not matter much to the asymptomatic person who’s been allowed to leave quarantine, but it could be devastating to vulnerable people in the community they come in contact with,” she added.

Economy over health?

Scientists fear that the decision to halve isolation times for asymptomatic and rapidly recovering patients is not being driven by public health concerns.

“It’s certainly not a public health guideline — it’s more towards [needing] to make sure that we are able to keep things running pretty much, so it’s more an economic guideline,” said Tobias Kurth, a professor of public health and epidemiology at Berlin’s Charite hospital.

“In some areas, it may be necessary to be able to relax the rule a little bit, but not as a general recommendation,” Kurth said.

Hyde echoed Kurth’s concern: “I worry that it’s politics driving this decision, not science.”

Hodcroft said the real solution to shortage of staff in the workplace would be to get case numbers down.

“By allowing those who could still be contagious back to a working environment, you may enable transmission, letting more people get infected, and potentially perpetuating the problem,” Hodcroft said. 

Pressure on hospitals

Another concern is how hospitals will cope if infection rates rise even higher as a result of asymptomatic people not being in isolation long enough and negative tests not being required.

Kurth warned that, in countries facing waves fueled by omicron — such as the UK, France, the US and Germany — the huge amount of cases will cause health care systems to collapse.

“It really seems like a terrible time to be easing restrictions with the omicron variant spreading so quickly; I can’t see how the hospital system is going to cope with this,” Hyde said.

The CDC’s decision comes as other countries start discussing changing isolation rules for people with different levels of vaccination.

Germany is currently mulling changes to isolation rules for people who have had contact with an infected person if they do not have symptoms.

But, unlike in the US recommendations for asymptomatic cases, a negative COVID-19 test would still be required.

Edited by: Fabian Schmidt 

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  Virus with a crown

  May we present: The coronavirus! This is how 10-year-old Andrej from Russia views SARS-CoV-2, the virus that causes COVID-19 and is behind the pandemic that’s had the world in its grip for almost two years now. The name for this virus family is derived from the Latin “corona” for crown. It was first used in 1968 and refers to the spike proteins on the virus’ surface.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  The real deal

  And this is what the novel coronavirus actually looks like. Each SARS-CoV-2 particle is about 80 nanometers in diameter. Each particle contains a ball of RNA, the virus’s genetic code. That is protected by spike protein, the protusions that gave the virus its name. SARS-CoV-2 is a member of the coronavirus family, which includes the viruses responsible for SARS and MERS. More on that later.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  An airborne virus

  SARS-CoV-2 particles are transferred through droplets and aerosols that a person emits when they breathe, cough or talk. That’s why face masks have become ubiquitous during the pandemic: Health authorities recommend citizens wear them to stop the spread of the virus. It can also be transmitted via contaminated surfaces.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  Entering human cells

  SARS-CoV-2 uses its spike proteins to bind with a protein on the surface of cells. That sets off chemical changes, which allow the virus’s RNA to enter the cell (green in this image). The virus then forces the cell to make copies of its RNA. A single cell can produce tens of thousands of new virus particles (purple in this image) like this, which then infect other healthy cells.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  New to humans

  Another electron microscope image of a cell (blue) heavily infected with SARS-CoV-2 particles (red). The virus behind our current pandemic isn’t too different from viruses like the ones causing the flu or common cold. But before 2019, human immune systems hadn’t seen this particular strain before, which is why no one had built up immunity.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  SARS-CoV: The first coronavirus outbreak of the 21st century

  The first time this century that humanity came in contact with a coronavirus was in China in 2002. In March 2003, the WHO issued a global alert warning of atypical pneumonia spreading quickly. SARS, or severe accute respiratory syndrome, spread to roughly 30 countries, but not all of these recorded deaths. The WHO declared the epidemic contained in July 2003.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  MERS-CoV, another coronavirus family member

  In 2012, researchers discovered MERS-CoV, a novel coronavirus, after genome sequencing of samples from people who had fallen ill with a new flu-like illness. This illness came to be known as MERS, or Middle East respiratory syndrome, after where the first outbreak occurred. It is less infectious than COVID-19. Transmission usually occurs among family members or in healthcare settings.

• 

  COVID: SARS-CoV-2 and other viruses in pictures

  HIV: The other pandemic

  The HI-virus (here in yellow), attacks the immune system, for examples T-cells (here in blue). Like SARS-CoV-2, it’s an RNA-based virus. If left untreated, it’ll weaken the immune system until it can’t fight infections anymore. HIV is transmitted through bodily fluids like semen or blood. There’s no vaccine, but there’s medication that brings down the viral load and stops AIDS from breaking out.

  Author: Carla Bleiker

COVID isolation cuts priotizes business over health, say scientists
Source: Pinoy Pop News